Secondary Logo

Journal Logo

The Artificial Pancreas

Coming to an OR Near You?

Wanderer, Jonathan P., MD, MPhil; Nathan, Naveen, MD

doi: 10.1213/ANE.0000000000004162
Infographics: Infographic
Free

Vanderbilt University School of Medicine (jon.wanderer@vanderbilt.edu)

Northwestern University Feinberg School of Medicine (n-nathan@northwestern.edu)

Published ahead of print 26 February 2019.

The Infographic is composed by Jonathan P. Wanderer, MD, MPhil, Vanderbilt University School of Medicine (jon.wanderer@vanderbilt.edu), and Naveen Nathan, MD, Northwestern University Feinberg School of Medicine (n-nathan@northwestern.edu). Illustration by Naveen Nathan, MD.

The authors declare no conflicts of interest.

Figure

Figure

One of the advances in the management of type 1 diabetes mellitus that holds significant potential to reduce the burden of disease management and improve the outcomes is the development of the control-to-target and control-to-range artificial pancreas devices. These devices use a continuous glucose monitor paired with an insulin pump and controller, which utilize algorithms to automatically adjust the rate of insulin administration throughout the day based on real-time glucose measurements. In this infographic, we review the overall functionality of these devices and summarize key considerations for the perioperative management of patients who present with these devices for surgical care.

Back to Top | Article Outline

REFERENCES

1. Long MT, Coursin DB, Rice MJPerioperative considerations for evolving artificial pancreas devices. Anesth Analg. 2019;128:902906.
    © 2019 International Anesthesia Research Society